Artemsinin based combination treatment
Showing 1 - 25 of >10,000
Locally Advanced Unresectable or Metastatic Esophageal Cancer Trial (Futibatinib, Pembrolizumab, Cisplatin)
Not yet recruiting
- Locally Advanced Unresectable or Metastatic Esophageal Cancer
- Futibatinib
- +6 more
- (no location specified)
Jul 6, 2023
Depression Trial in Kudus (Combination mindfulness spiritual-based cognitive therapy plus hypnosis, Mindfulness-based cognitive
Completed
- Depression
- Combination mindfulness spiritual-based cognitive therapy plus hypnosis
- Mindfulness-based cognitive therapy
-
Kudus, Middle Java, IndonesiaEny Pujiati
Dec 12, 2022
NSCLC Trial (Durvalumab, Tremelimumab, Pemetrexed)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Durvalumab
- +5 more
- (no location specified)
Aug 17, 2023
Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)
Not yet recruiting
- Non Small Cell Lung Cancer
- Propranolol
- Propranolol hydrochloride
- +2 more
- (no location specified)
Jul 31, 2023
Metastatic Cervical Cancer Trial (Tislelizumab, Sitravatinib)
Not yet recruiting
- Metastatic Cervical Cancer
- (no location specified)
Jan 31, 2023
Pancreatic Ductal Adenocarcinoma Trial (combination therapy with no MEKi, combination therapy with MEKi-HCQ, combination therapy
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- combination therapy with no MEKi
- +3 more
- (no location specified)
Nov 29, 2022
Advanced Solid Tumor, Platinum-Resistant Ovarian Cancer, Platinum-Resistant Urothelial Carcinoma Trial in Darlinghurst, Kogarah,
Terminated
- Advanced Solid Tumor
- +3 more
- NTX-301
- +2 more
-
Darlinghurst, New South Wales, Australia
- +1 more
Dec 18, 2022
Anemia, Decreased Glomerular Filtration Rate Trial in Houston (consultation with a specialist, Usual care)
Not yet recruiting
- Anemia
- Decreased Glomerular Filtration Rate
- consultation with a specialist
- Usual care
-
Houston, TexasThe University of Texas Health Science Center at Houston
Feb 16, 2023
Cancer, Gastro-Intestinal Intraepithelial Neoplasia Trial in Jerusalem (Promitil)
Active, not recruiting
- Cancer
- Gastro-Intestinal Intraepithelial Neoplasia
-
Jerusalem, IsraelShaare Zedek Medical Center
Dec 21, 2022
Osteo Arthritis Knee Trial in St. Pölten, St. Poelten (GLAD training program in combination with nutrition therapy based on the
Recruiting
- Osteo Arthritis Knee
- GLAD training program in combination with nutrition therapy based on the New Nordic Niet
-
St. Pölten, Lower Austria, Austria
- +1 more
Jul 12, 2023
Uncomplicated Plasmodium Falciparum Malaria Trial in Bagamoyo (Artemether-lumefantrine and Amodiaquine Drug Combination,
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- Artemether-lumefantrine and Amodiaquine Drug Combination
- +2 more
-
Bagamoyo, Dar esSalaam, Tanzania
- +1 more
Feb 28, 2023
Fibromyalgia, Pain, Psychology Regression Trial in Istanbul (Pain neuroscience education (PNE), Motor imagery-based exercise
Completed
- Fibromyalgia
- +2 more
- Pain neuroscience education (PNE)
- +2 more
-
Istanbul, TurkeyUskudar University
May 25, 2023
Small Cell Lung Cancer Trial in Nice (acetazolamide in combination with platinum and etoposide-based radiochemo)
Recruiting
- Small Cell Lung Cancer
- acetazolamide in combination with platinum and etoposide-based radiochemotherapy
-
Nice, FranceCentre Antoine Lacassagne
Jan 19, 2023
Small Cell Lung Cancer, SCLC, Extensive Stage Small Cell Lung Cancer Trial (Durvalumab, Monalizumab, Carboplatin or Cisplatin)
Not yet recruiting
- Small Cell Lung Cancer
- +2 more
- Durvalumab
- +3 more
- (no location specified)
Jun 5, 2023
Recurrent or Metastatic Colorectal Cancer Trial (Nelmastobart and Capecitabine)
Not yet recruiting
- Recurrent or Metastatic Colorectal Cancer
- Nelmastobart and Capecitabine
- (no location specified)
Aug 6, 2023
Primary Hepatocellular Carcinoma, Portal Vein Thrombosis Trial (Recombinant human adenovirus type 5 + TACE)
Not yet recruiting
- Primary Hepatocellular Carcinoma
- Portal Vein Thrombosis
- Recombinant human adenovirus type 5 + TACE
- (no location specified)
May 14, 2023
Newly-diagnosed PCNSL Treated WithMethotrexate and
Active, not recruiting
- Primary Central Nervous System Lymphoma
-
Shanghai, ChinaDepartment of Hematology, Huashan Hospital, Fudan University
Oct 30, 2023
Cerebral Palsy Trial in Al Kharj (Pilates-based Core Strengthening Exercises, Plyometric-based Muscle Loading Exercises,
Completed
- Cerebral Palsy
- Pilates-based Core Strengthening Exercises
- +2 more
-
Al Kharj, Riyadh, Saudi ArabiaRagab K. Elnaggar
Jun 18, 2022
Hematological Malignancy, Leukemia, Multiple Myeloma Trial in Milwaukee (Evomela, Fludarabine, Total Body Irradiation)
Recruiting
- Hematological Malignancy
- Multiple Myeloma
- Evomela
- +2 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Oct 4, 2022
Diabetes, Type 2 Trial (Empagliflozin 25 MG, INS)
Active, not recruiting
- Diabetes Mellitus, Type 2
- Empagliflozin 25 MG
- INS
- (no location specified)
Jul 19, 2022
Depressive Disorder Trial in Zhejiang (Antidepressant, Psychotherapy IPT, The combination of antidepressant and IPT)
Recruiting
- Depressive Disorder
- Antidepressant
- +2 more
-
Zhejiang, Hangzhou, ChinaThe First Affiliated Hospital of Zhejiang University
Jun 23, 2023
Small Cell Lung Cancer Recurrent Trial in Madrid, Pamplona, Valencia (Debio 0123, Etoposide, Carboplatin)
Not yet recruiting
- Small Cell Lung Cancer Recurrent
- Debio 0123
- +2 more
-
Madrid, Spain
- +3 more
Apr 3, 2023
MDD Trial in Columbus (Combination use of MBCT and IV Ketamine)
Recruiting
- Major Depressive Disorder
- Combination use of MBCT and IV Ketamine
-
Columbus, OhioHarding Hospital
Jul 10, 2023
